Events and resources to
help you stay informed

Sam, age 10, living with NF1 PN.
Sam is taking Koselugo.

Sam, a 10-year-old who takes Koselugo for  NF1 PN, sitting on a couch and smiling

Sam, age 10, living with NF1 PN.
Sam is taking Koselugo.

Educational events

Attend a free webinar or in-person event to learn about neurofibromatosis type 1 (NF1) plexiform neurofibromas and treatment with Koselugo.

Helpful downloads

The following resources provide information about plexiform neurofibromas, treatment with Koselugo, and support from your Koselugo team. As you review the materials, write down your questions and share them with your child's care team during your next visit.

Basics Brochure for Caregivers thumbnail

Basics Brochure for Caregivers

Download this brochure to learn more about NF1 plexiform neurofibromas and treatment with Koselugo.

Download
Doctor Discussion Guide thumbnail

Doctor Discussion Guide

Download this resource to help guide your conversations about treatment with your care team.

Download
Pill Swallowing Guide thumbnail

Pill Swallowing Guide

Download this guide to get tips for helping your child feel comfortable swallowing pills.

Download
Treatment Tracking Journal thumbnail

Treatment Tracking Journal

Download this booklet to record your child’s treatment, and write down notes about their treatment so you can discuss them with your child’s doctor at their next appointment.

Download
Personalized Support Flyer thumbnail

Personalized Support Flyer

Download this guide to learn about the 2 unique support teams available to caregivers through OneSource™.

Download
OneSourceTM Brochure thumbnail

OneSource Brochure

Download this brochure to learn about the many ways OneSource can support you and your child throughout your child's treatment journey.

Download

The Parent Readiness Kit

The Parent Readiness Kit is here to help you learn about Koselugo. It provides useful resources, including information on how to monitor symptoms and how to enroll in OneSource, a free, personalized support program offered by Alexion. Click the "+" symbol in the visual below to see a description of each resource.

Request a kit
Parent Readiness Kit: Table of Contents,  OneSource^TM Brochure, Personalized  Support Flyer, Basics Brochure for  Caregivers, OneSource^TM Enrollment  Form, Parent Readiness Workbook, Next  Steps After Starting Flyer, Koselugo  Treatment Tracking Journal

What's inside the kit

Parent Readiness Kit Table of Contents
Parent Readiness Kit Table of Contents

An overview of resources included in the Parent Readiness Kit.

OneSourceTM Brochure
OneSourceTM Brochure

An overview of services provided by OneSource™.

OneSourceTM Enrollment Form 
OneSourceTM Enrollment Form 

An essential form to sign up for OneSource™ to start receiving treatment support.

Parent Readiness Workbook 
Parent Readiness Workbook 

An interactive guide with information about Koselugo dosing, treatment routines, and available support.

Personalized Support Flyer
Personalized Support Flyer

Information for caregivers about connecting with Patient Education Managers (PEMs) and Case Managers.

Next Steps After Starting Flyer 
Next Steps After Starting Flyer 

Information for caregivers after their children have started treatment with Koselugo.

Basics Brochure for Caregivers
Basics Brochure for Caregivers

Detailed information on how Koselugo works and what to expect while taking treatment.

Koselugo Treatment Tracking Journal
Koselugo Treatment Tracking Journal

A resource for caregivers to monitor and track side effects while their child is on Koselugo.

Frequently Asked Questions

STAY INFORMED ABOUT NF1 PLEXIFORM NEUROFIBROMAS

To receive the latest updates, tools, and tips about NF1 plexiform neurofibromas and Koselugo, please provide us with some information about yourself.

Please enter First Name

Please enter Last Name

Please enter Email

Please enter ZIP code

*Required

Please confirm

important safety information

What are the possible side effects of Koselugo?

Koselugo may cause serious side effects, including:

  • Heart problems. Koselugo can lower the amount of blood pumped by your heart, which is common and can also be severe. Your healthcare provider will do tests before and during treatment to check how well your heart is working. Tell your healthcare provider right away if you get any of the following signs or symptoms: persistent coughing or wheezing, shortness of breath, swelling of your ankles and feet, tiredness, increased heart rate.
  • Eye problems. Koselugo can cause eye problems that can lead to blindness. Your healthcare provider will check your vision before and during treatment. Tell your healthcare provider right away if you get any of the following signs or symptoms: blurred vision, loss of vision, dark spots in your vision (floaters), other changes to your vision.
  • Severe diarrhea. Diarrhea is common with Koselugo and can also be severe. Tell your healthcare provider right away the first time that you get diarrhea during treatment. Your healthcare provider may give you medicine to help control your diarrhea and may tell you to drink more fluids.
  • Skin rash. Skin rashes are common with Koselugo and can also be severe. Tell your healthcare provider if you get any of the following signs or symptoms: rash that covers a large area of your body, peeling skin, blisters.
  • Muscle problems (rhabdomyolysis). Muscle problems are common with Koselugo and can also be severe. Treatment with Koselugo may increase the level of a muscle enzyme in your blood called creatine phosphokinase (CPK) and may be a sign of muscle damage. Your healthcare provider should do a blood test to check your muscle enzyme levels of CPK before you start taking Koselugo and during treatment. Tell your healthcare provider right away if you get any of the following signs or symptoms: muscle aches or pain; muscle spasms and weakness; dark, reddish urine.

Before taking Koselugo, tell your healthcare provider about all your medical conditions, including if you:

  • have heart problems.
  • have eye problems.
  • have liver problems.
  • are pregnant or plan to become pregnant. Koselugo can harm your unborn baby. Your healthcare provider should verify if you/your partner are pregnant before beginning treatment. Ensure you/your partner use effective birth control (contraception) during treatment and for 1 week after your last dose if there is possibility pregnancy could occur. Tell your healthcare provider right away if you/your partner think you may be pregnant.
  • are breastfeeding or plan to breastfeed. It is not known if Koselugo passes into your breast milk. Do not breastfeed during treatment and for 1 week after your last dose. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all the medicines you take, including prescription, over-the-counter medicines, vitamins, or herbal supplements. Especially tell your healthcare provider if you are taking aspirin, blood thinners, or other medicines to treat blood clots. Koselugo contains vitamin E, which may increase risk of bleeding.

What should I avoid while taking Koselugo?

Do not drink grapefruit juice, eat grapefruit, or take supplements with grapefruit or St. John’s Wort during treatment.

Most common side effects include: vomiting, stomach-area pain, nausea, dry skin, muscle and bone pain, feeling of tiredness or lacking energy, fever, sores in your mouth, headache, redness around the fingernails, itching.

These are not all the possible side effects of Koselugo. Call your healthcare provider for medical advice about side effects. Your healthcare provider may change your dose, temporarily stop, or permanently ask you to stop taking Koselugo if you have any of these side effects. You may report side effects to AstraZeneca at 1-800-236-9933 or at https://
us-aereporting.astrazeneca.com
or FDA at
1-800-FDA-1088 or
www.fda.gov/medwatch.

Indication

What is Koselugo?

Koselugo is a prescription medicine that is used to treat children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas that cannot be completely removed by surgery. It is not known if Koselugo is safe and effective in children under 2 years of age.

All families shown in this website have been compensated by Alexion, unless otherwise noted.